Rank | Gene Set | Z-score |
---|---|---|
1 | blood coagulation, intrinsic pathway (GO:0007597) | 5.47181252 |
2 | axon ensheathment in central nervous system (GO:0032291) | 5.28643375 |
3 | central nervous system myelination (GO:0022010) | 5.28643375 |
4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.76384032 |
5 | negative regulation of heart rate (GO:0010459) | 4.74138941 |
6 | negative regulation of norepinephrine secretion (GO:0010700) | 4.54291876 |
7 | fatty acid elongation (GO:0030497) | 4.40669530 |
8 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.21231121 |
9 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.17411072 |
10 | polyamine biosynthetic process (GO:0006596) | 4.14789071 |
11 | negative regulation of appetite (GO:0032099) | 4.05550085 |
12 | negative regulation of response to food (GO:0032096) | 4.05550085 |
13 | chaperone-mediated protein transport (GO:0072321) | 3.97984299 |
14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.95381447 |
15 | regulation of lipoprotein metabolic process (GO:0050746) | 3.94092747 |
16 | thrombin receptor signaling pathway (GO:0070493) | 3.92977682 |
17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.92240423 |
18 | L-phenylalanine catabolic process (GO:0006559) | 3.91442815 |
19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91442815 |
20 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89392311 |
21 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.88442566 |
22 | L-phenylalanine metabolic process (GO:0006558) | 3.82988639 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.82988639 |
24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.76192292 |
25 | ATP synthesis coupled proton transport (GO:0015986) | 3.76192292 |
26 | adenosine receptor signaling pathway (GO:0001973) | 3.69186660 |
27 | establishment of mitochondrion localization (GO:0051654) | 3.68311304 |
28 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.65158215 |
29 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.64202060 |
30 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.63043397 |
31 | negative regulation of catecholamine secretion (GO:0033604) | 3.55984065 |
32 | negative regulation of protein localization to cell surface (GO:2000009) | 3.55662360 |
33 | substantia nigra development (GO:0021762) | 3.54785979 |
34 | lipoxygenase pathway (GO:0019372) | 3.50320826 |
35 | respiratory electron transport chain (GO:0022904) | 3.45849353 |
36 | neuronal action potential propagation (GO:0019227) | 3.44899538 |
37 | neutrophil activation involved in immune response (GO:0002283) | 3.44570463 |
38 | electron transport chain (GO:0022900) | 3.39898951 |
39 | mitochondrial calcium ion transport (GO:0006851) | 3.34462990 |
40 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.31706274 |
41 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.31706274 |
42 | peroxisome fission (GO:0016559) | 3.28392578 |
43 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.26857580 |
44 | synaptic vesicle exocytosis (GO:0016079) | 3.26272164 |
45 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.26114496 |
46 | glutamate secretion (GO:0014047) | 3.24031310 |
47 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23318091 |
48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.22247721 |
49 | synaptic vesicle maturation (GO:0016188) | 3.22090446 |
50 | regulation of platelet activation (GO:0010543) | 3.21059322 |
51 | platelet aggregation (GO:0070527) | 3.15515484 |
52 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.15170924 |
53 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.15149215 |
54 | polyamine metabolic process (GO:0006595) | 3.14782669 |
55 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.14208233 |
56 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.13431397 |
57 | negative regulation of heart contraction (GO:0045822) | 3.12666873 |
58 | reverse cholesterol transport (GO:0043691) | 3.09593018 |
59 | neuromuscular process controlling posture (GO:0050884) | 3.09403119 |
60 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07176202 |
61 | cholesterol biosynthetic process (GO:0006695) | 3.06803437 |
62 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.05917417 |
63 | platelet degranulation (GO:0002576) | 3.05057252 |
64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.04104679 |
65 | negative regulation of cation channel activity (GO:2001258) | 3.02510240 |
66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.97266213 |
67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.97266213 |
68 | NADH dehydrogenase complex assembly (GO:0010257) | 2.97266213 |
69 | regulation of platelet aggregation (GO:0090330) | 2.96490747 |
70 | negative regulation of platelet activation (GO:0010544) | 2.94332036 |
71 | ensheathment of neurons (GO:0007272) | 2.92744460 |
72 | axon ensheathment (GO:0008366) | 2.92744460 |
73 | coenzyme catabolic process (GO:0009109) | 2.92733153 |
74 | myelination (GO:0042552) | 2.92611314 |
75 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.91423506 |
76 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.91423506 |
77 | relaxation of smooth muscle (GO:0044557) | 2.91146869 |
78 | phospholipid homeostasis (GO:0055091) | 2.90700536 |
79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.90020909 |
80 | regulation of oxidative phosphorylation (GO:0002082) | 2.89652274 |
81 | dopamine transport (GO:0015872) | 2.88408781 |
82 | regulation of norepinephrine secretion (GO:0014061) | 2.88170428 |
83 | protein complex biogenesis (GO:0070271) | 2.88061854 |
84 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.87327540 |
85 | aspartate family amino acid catabolic process (GO:0009068) | 2.86786157 |
86 | positive regulation of hemostasis (GO:1900048) | 2.86470135 |
87 | positive regulation of blood coagulation (GO:0030194) | 2.86470135 |
88 | neurotransmitter catabolic process (GO:0042135) | 2.83654085 |
89 | protein neddylation (GO:0045116) | 2.83364878 |
90 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.82219236 |
91 | neurotransmitter uptake (GO:0001504) | 2.79270423 |
92 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.77541406 |
93 | peptidyl-cysteine modification (GO:0018198) | 2.76399579 |
94 | heme transport (GO:0015886) | 2.75658857 |
95 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.75372433 |
96 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.74248870 |
97 | response to methylmercury (GO:0051597) | 2.73851796 |
98 | negative regulation of microtubule polymerization (GO:0031115) | 2.72698711 |
99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.72521076 |
100 | cyclooxygenase pathway (GO:0019371) | 2.71635671 |
101 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.71088520 |
102 | neuron cell-cell adhesion (GO:0007158) | 2.70900980 |
103 | amino acid salvage (GO:0043102) | 2.70722002 |
104 | L-methionine salvage (GO:0071267) | 2.70722002 |
105 | L-methionine biosynthetic process (GO:0071265) | 2.70722002 |
106 | detection of temperature stimulus (GO:0016048) | 2.69026508 |
107 | regulation of dopamine metabolic process (GO:0042053) | 2.68253802 |
108 | regulation of catecholamine metabolic process (GO:0042069) | 2.68253802 |
109 | dicarboxylic acid catabolic process (GO:0043649) | 2.67268233 |
110 | sterol biosynthetic process (GO:0016126) | 2.66953474 |
111 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.65957392 |
112 | iron coordination entity transport (GO:1901678) | 2.65023250 |
113 | negative regulation of neurotransmitter transport (GO:0051589) | 2.64543838 |
114 | protein deneddylation (GO:0000338) | 2.62552180 |
115 | negative regulation of blood circulation (GO:1903523) | 2.62299142 |
116 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.62140087 |
117 | regulation of cholesterol esterification (GO:0010872) | 2.61188858 |
118 | glycerophospholipid catabolic process (GO:0046475) | 2.61135954 |
119 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.60461992 |
120 | heart process (GO:0003015) | 2.60409213 |
121 | heart contraction (GO:0060047) | 2.60409213 |
122 | regulation of response to food (GO:0032095) | 2.60134587 |
123 | gamma-aminobutyric acid transport (GO:0015812) | 2.60070014 |
124 | sequestering of actin monomers (GO:0042989) | 2.59802000 |
125 | positive regulation of coagulation (GO:0050820) | 2.59743966 |
126 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.58418539 |
127 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.58149154 |
128 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.57730014 |
129 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.57513662 |
130 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.57471489 |
131 | beta-amyloid metabolic process (GO:0050435) | 2.57456671 |
132 | cellular response to leptin stimulus (GO:0044320) | 2.57359077 |
133 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.56994389 |
134 | ether lipid metabolic process (GO:0046485) | 2.55757895 |
135 | ATP biosynthetic process (GO:0006754) | 2.55748896 |
136 | tonic smooth muscle contraction (GO:0014820) | 2.55596924 |
137 | oxidative phosphorylation (GO:0006119) | 2.55411114 |
138 | very long-chain fatty acid metabolic process (GO:0000038) | 2.55403040 |
139 | thioester biosynthetic process (GO:0035384) | 2.54978579 |
140 | acyl-CoA biosynthetic process (GO:0071616) | 2.54978579 |
141 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.54413597 |
142 | regulation of collateral sprouting (GO:0048670) | 2.54013094 |
143 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.53398422 |
144 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53244768 |
145 | regulation of receptor recycling (GO:0001919) | 2.52330372 |
146 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.51869447 |
147 | mitochondrion transport along microtubule (GO:0047497) | 2.50206994 |
148 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.50206994 |
149 | positive regulation of mitochondrial fission (GO:0090141) | 2.49587755 |
150 | relaxation of muscle (GO:0090075) | 2.47836075 |
151 | cofactor catabolic process (GO:0051187) | 2.46679774 |
152 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46649575 |
153 | dopamine biosynthetic process (GO:0042416) | 2.45510919 |
154 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.45125091 |
155 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.44652206 |
156 | positive regulation of TOR signaling (GO:0032008) | 2.44432384 |
157 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.44182441 |
158 | protein localization to synapse (GO:0035418) | 2.43799218 |
159 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.43522710 |
160 | negative regulation of amine transport (GO:0051953) | 2.43411092 |
161 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.42089721 |
162 | tyrosine metabolic process (GO:0006570) | 2.41448278 |
163 | response to redox state (GO:0051775) | 2.40710584 |
164 | linoleic acid metabolic process (GO:0043651) | 2.39429629 |
165 | adult walking behavior (GO:0007628) | 2.38961887 |
166 | cellular response to glucagon stimulus (GO:0071377) | 2.38843588 |
167 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.38558004 |
168 | regulation of protein localization to cell surface (GO:2000008) | 2.38545927 |
169 | protein maturation by protein folding (GO:0022417) | 2.37617156 |
170 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.36779014 |
171 | response to misfolded protein (GO:0051788) | 2.36514021 |
172 | response to mercury ion (GO:0046689) | 2.36408600 |
173 | neural nucleus development (GO:0048857) | 2.36198547 |
174 | glutathione biosynthetic process (GO:0006750) | 2.35535586 |
175 | cullin deneddylation (GO:0010388) | 2.34857394 |
176 | behavioral response to cocaine (GO:0048148) | 2.34750165 |
177 | neurotransmitter secretion (GO:0007269) | 2.34241716 |
178 | neurofilament cytoskeleton organization (GO:0060052) | 2.33518153 |
179 | hydrogen ion transmembrane transport (GO:1902600) | 2.33462586 |
180 | cysteine metabolic process (GO:0006534) | 2.33125066 |
181 | regulation of synaptic vesicle transport (GO:1902803) | 2.33005138 |
182 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.32908098 |
183 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.32908098 |
184 | aromatic amino acid family catabolic process (GO:0009074) | 2.31910193 |
185 | neurotransmitter transport (GO:0006836) | 2.31773051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.28637019 |
2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.23235434 |
3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.88667120 |
4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.74539714 |
5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.61770425 |
6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.58469088 |
7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.33738845 |
8 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24102195 |
9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.23452468 |
10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.21694506 |
11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.20410914 |
12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19281053 |
13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17637505 |
14 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11879996 |
15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09368716 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03632980 |
17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02431742 |
18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01334906 |
19 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00365090 |
20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87516221 |
21 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.76911839 |
22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.74889312 |
23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.70578750 |
24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67985112 |
25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67278311 |
26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65963695 |
27 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59823779 |
28 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57458535 |
29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.53883853 |
30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53860399 |
31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52333500 |
32 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49986119 |
33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48536275 |
34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47995251 |
35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46437080 |
36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45761099 |
37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45761099 |
38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43408795 |
39 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.42814420 |
40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.42252780 |
41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39765569 |
42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38397274 |
43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.36577700 |
44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35995270 |
45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35976929 |
46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33516167 |
47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32300934 |
48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32190432 |
49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32190432 |
50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31135675 |
51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30461566 |
52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28730192 |
53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28363947 |
54 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.27987386 |
55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27829317 |
56 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25713754 |
57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.25471474 |
58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25332250 |
59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24815646 |
60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24400725 |
61 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23209376 |
62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22906098 |
63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20949003 |
64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20779362 |
65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19906427 |
66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18477316 |
67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18402406 |
68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18104804 |
69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17968326 |
70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17903479 |
71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17754214 |
72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17514946 |
73 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.17181657 |
74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16073371 |
75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14655168 |
76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14218495 |
77 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13858245 |
78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13757971 |
79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13173854 |
80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12722791 |
81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.12564012 |
82 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11985381 |
83 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.11159784 |
84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11000818 |
85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10950074 |
86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09645990 |
87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09553263 |
88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09056808 |
89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07768072 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07722458 |
91 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07657853 |
92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06930997 |
93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06702120 |
94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05112685 |
95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04320678 |
96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04047815 |
97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03559869 |
98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02780210 |
99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02350678 |
100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02232781 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02221623 |
102 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01329995 |
103 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01164528 |
104 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.00566522 |
105 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00415547 |
106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99542960 |
107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99030692 |
108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98985829 |
109 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.98630465 |
110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98611935 |
111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98405185 |
112 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.98278063 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98272215 |
114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98132616 |
115 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97685936 |
116 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97681265 |
117 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96443580 |
118 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95489910 |
119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95460336 |
120 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94087984 |
121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93842913 |
122 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93124255 |
123 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90906243 |
124 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90760600 |
125 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90751694 |
126 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90329191 |
127 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89889933 |
128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89723043 |
129 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.89338287 |
130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88716801 |
131 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87930567 |
132 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87654118 |
133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87632617 |
134 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.87591937 |
135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87394577 |
136 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87111686 |
137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86835567 |
138 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86665557 |
139 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86202821 |
140 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85917428 |
141 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84909488 |
142 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.84787158 |
143 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83662687 |
144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83602737 |
145 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83130616 |
146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82759622 |
147 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82414698 |
148 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81791257 |
149 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81398334 |
150 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81385339 |
151 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.81383761 |
152 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81340286 |
153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81255484 |
154 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81193108 |
155 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81163317 |
156 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80711236 |
157 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80711127 |
158 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.80176446 |
159 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80063247 |
160 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.79031765 |
161 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.78384678 |
162 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78161719 |
163 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.77685031 |
164 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.77257154 |
165 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76826337 |
166 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.75895789 |
167 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75793361 |
168 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.74518081 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 6.38555521 |
2 | MP0008004_abnormal_stomach_pH | 3.65506939 |
3 | MP0004270_analgesia | 3.42159557 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.41119710 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.23556773 |
6 | MP0001529_abnormal_vocalization | 3.17766413 |
7 | MP0003880_abnormal_central_pattern | 2.83366945 |
8 | MP0004859_abnormal_synaptic_plasticity | 2.74906199 |
9 | MP0005360_urolithiasis | 2.62721014 |
10 | MP0002734_abnormal_mechanical_nocicepti | 2.42402201 |
11 | MP0004036_abnormal_muscle_relaxation | 2.41050776 |
12 | MP0002272_abnormal_nervous_system | 2.26624336 |
13 | MP0004215_abnormal_myocardial_fiber | 2.26554676 |
14 | MP0004084_abnormal_cardiac_muscle | 2.25862734 |
15 | MP0004142_abnormal_muscle_tone | 2.24590277 |
16 | MP0001905_abnormal_dopamine_level | 2.18948394 |
17 | MP0003635_abnormal_synaptic_transmissio | 2.18014736 |
18 | MP0002064_seizures | 2.13304892 |
19 | MP0001968_abnormal_touch/_nociception | 2.09322865 |
20 | MP0003329_amyloid_beta_deposits | 2.08113888 |
21 | MP0005670_abnormal_white_adipose | 2.07466106 |
22 | MP0005085_abnormal_gallbladder_physiolo | 2.06644965 |
23 | MP0009745_abnormal_behavioral_response | 2.05185301 |
24 | MP0004147_increased_porphyrin_level | 2.00244416 |
25 | MP0006276_abnormal_autonomic_nervous | 1.95860717 |
26 | MP0004885_abnormal_endolymph | 1.95845584 |
27 | MP0000920_abnormal_myelination | 1.91403796 |
28 | MP0004043_abnormal_pH_regulation | 1.90032869 |
29 | MP0009046_muscle_twitch | 1.84478920 |
30 | MP0002735_abnormal_chemical_nociception | 1.84187757 |
31 | MP0000465_gastrointestinal_hemorrhage | 1.81537429 |
32 | MP0002736_abnormal_nociception_after | 1.78061574 |
33 | MP0002822_catalepsy | 1.77909530 |
34 | MP0002733_abnormal_thermal_nociception | 1.77805379 |
35 | MP0002234_abnormal_pharynx_morphology | 1.74978286 |
36 | MP0001986_abnormal_taste_sensitivity | 1.68171308 |
37 | MP0005167_abnormal_blood-brain_barrier | 1.67475706 |
38 | MP0002063_abnormal_learning/memory/cond | 1.67396924 |
39 | MP0001486_abnormal_startle_reflex | 1.66808182 |
40 | MP0001970_abnormal_pain_threshold | 1.66774972 |
41 | MP0002572_abnormal_emotion/affect_behav | 1.66288189 |
42 | MP0003122_maternal_imprinting | 1.65571036 |
43 | MP0003186_abnormal_redox_activity | 1.58542800 |
44 | MP0005084_abnormal_gallbladder_morpholo | 1.57832585 |
45 | MP0005646_abnormal_pituitary_gland | 1.55868083 |
46 | MP0008775_abnormal_heart_ventricle | 1.54294666 |
47 | MP0010329_abnormal_lipoprotein_level | 1.49374659 |
48 | MP0006036_abnormal_mitochondrial_physio | 1.49061286 |
49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48916772 |
50 | MP0004130_abnormal_muscle_cell | 1.48890529 |
51 | MP0005423_abnormal_somatic_nervous | 1.46872280 |
52 | MP0009780_abnormal_chondrocyte_physiolo | 1.45458342 |
53 | MP0005187_abnormal_penis_morphology | 1.45362316 |
54 | MP0009379_abnormal_foot_pigmentation | 1.42853029 |
55 | MP0001485_abnormal_pinna_reflex | 1.42163988 |
56 | MP0005386_behavior/neurological_phenoty | 1.41551755 |
57 | MP0004924_abnormal_behavior | 1.41551755 |
58 | MP0002972_abnormal_cardiac_muscle | 1.40565240 |
59 | MP0000343_altered_response_to | 1.40069030 |
60 | MP0000955_abnormal_spinal_cord | 1.37422948 |
61 | MP0002067_abnormal_sensory_capabilities | 1.37283877 |
62 | MP0003787_abnormal_imprinting | 1.35979715 |
63 | MP0002229_neurodegeneration | 1.34739246 |
64 | MP0001440_abnormal_grooming_behavior | 1.34248736 |
65 | MP0000778_abnormal_nervous_system | 1.33676718 |
66 | MP0005365_abnormal_bile_salt | 1.33274708 |
67 | MP0003950_abnormal_plasma_membrane | 1.33181658 |
68 | MP0005666_abnormal_adipose_tissue | 1.32259820 |
69 | MP0000230_abnormal_systemic_arterial | 1.28012463 |
70 | MP0004085_abnormal_heartbeat | 1.24919746 |
71 | MP0004858_abnormal_nervous_system | 1.22663718 |
72 | MP0005620_abnormal_muscle_contractility | 1.22342388 |
73 | MP0009697_abnormal_copulation | 1.22123911 |
74 | MP0002909_abnormal_adrenal_gland | 1.21441672 |
75 | MP0005083_abnormal_biliary_tract | 1.19374434 |
76 | MP0005332_abnormal_amino_acid | 1.18068861 |
77 | MP0006035_abnormal_mitochondrial_morpho | 1.17050169 |
78 | MP0008872_abnormal_physiological_respon | 1.17009017 |
79 | MP0004510_myositis | 1.16377514 |
80 | MP0005451_abnormal_body_composition | 1.16193902 |
81 | MP0002837_dystrophic_cardiac_calcinosis | 1.15762161 |
82 | MP0003638_abnormal_response/metabolism_ | 1.15745227 |
83 | MP0005058_abnormal_lysosome_morphology | 1.15170383 |
84 | MP0008569_lethality_at_weaning | 1.14760387 |
85 | MP0004133_heterotaxia | 1.13434560 |
86 | MP0002090_abnormal_vision | 1.13432195 |
87 | MP0002882_abnormal_neuron_morphology | 1.13208380 |
88 | MP0002184_abnormal_innervation | 1.13037057 |
89 | MP0002066_abnormal_motor_capabilities/c | 1.12821971 |
90 | MP0001188_hyperpigmentation | 1.10726018 |
91 | MP0009840_abnormal_foam_cell | 1.08241288 |
92 | MP0002638_abnormal_pupillary_reflex | 1.06358924 |
93 | MP0001984_abnormal_olfaction | 1.04827456 |
94 | MP0003656_abnormal_erythrocyte_physiolo | 1.03693078 |
95 | MP0003011_delayed_dark_adaptation | 1.02907740 |
96 | MP0002557_abnormal_social/conspecific_i | 1.02077200 |
97 | MP0002653_abnormal_ependyma_morphology | 1.00698934 |
98 | MP0003634_abnormal_glial_cell | 1.00607535 |
99 | MP0003123_paternal_imprinting | 1.00255019 |
100 | MP0003632_abnormal_nervous_system | 0.98302693 |
101 | MP0005551_abnormal_eye_electrophysiolog | 0.97054264 |
102 | MP0001544_abnormal_cardiovascular_syste | 0.95813490 |
103 | MP0005385_cardiovascular_system_phenoty | 0.95813490 |
104 | MP0005266_abnormal_metabolism | 0.95696913 |
105 | MP0001666_abnormal_nutrient_absorption | 0.95620134 |
106 | MP0003631_nervous_system_phenotype | 0.95242409 |
107 | MP0004145_abnormal_muscle_electrophysio | 0.94558682 |
108 | MP0004811_abnormal_neuron_physiology | 0.94413673 |
109 | MP0006138_congestive_heart_failure | 0.91774969 |
110 | MP0002118_abnormal_lipid_homeostasis | 0.91122804 |
111 | MP0003195_calcinosis | 0.91121313 |
112 | MP0001756_abnormal_urination | 0.89938747 |
113 | MP0003633_abnormal_nervous_system | 0.89615933 |
114 | MP0005501_abnormal_skin_physiology | 0.89583718 |
115 | MP0003868_abnormal_feces_composition | 0.89536220 |
116 | MP0003690_abnormal_glial_cell | 0.89433579 |
117 | MP0000749_muscle_degeneration | 0.88913080 |
118 | MP0005636_abnormal_mineral_homeostasis | 0.88567764 |
119 | MP0002752_abnormal_somatic_nervous | 0.86439963 |
120 | MP0003121_genomic_imprinting | 0.85785960 |
121 | MP0001963_abnormal_hearing_physiology | 0.85380966 |
122 | MP0005535_abnormal_body_temperature | 0.85298140 |
123 | MP0005645_abnormal_hypothalamus_physiol | 0.84249897 |
124 | MP0000747_muscle_weakness | 0.83930613 |
125 | MP0000639_abnormal_adrenal_gland | 0.83330329 |
126 | MP0005499_abnormal_olfactory_system | 0.82965473 |
127 | MP0005394_taste/olfaction_phenotype | 0.82965473 |
128 | MP0002332_abnormal_exercise_endurance | 0.81641407 |
129 | MP0004484_altered_response_of | 0.80689965 |
130 | MP0000462_abnormal_digestive_system | 0.80397003 |
131 | MP0004742_abnormal_vestibular_system | 0.79955435 |
132 | MP0002152_abnormal_brain_morphology | 0.79646719 |
133 | MP0005408_hypopigmentation | 0.79228766 |
134 | MP0001664_abnormal_digestion | 0.78557357 |
135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76748261 |
136 | MP0003137_abnormal_impulse_conducting | 0.76372703 |
137 | MP0000358_abnormal_cell_content/ | 0.74523032 |
138 | MP0009642_abnormal_blood_homeostasis | 0.73537007 |
139 | MP0005248_abnormal_Harderian_gland | 0.72715005 |
140 | MP0003718_maternal_effect | 0.72664205 |
141 | MP0000604_amyloidosis | 0.72344048 |
142 | MP0008789_abnormal_olfactory_epithelium | 0.71842579 |
143 | MP0001502_abnormal_circadian_rhythm | 0.71794028 |
144 | MP0002233_abnormal_nose_morphology | 0.71793491 |
145 | MP0002078_abnormal_glucose_homeostasis | 0.71366332 |
146 | MP0006072_abnormal_retinal_apoptosis | 0.71112666 |
147 | MP0003566_abnormal_cell_adhesion | 0.70494099 |
148 | MP0001764_abnormal_homeostasis | 0.69811613 |
149 | MP0005410_abnormal_fertilization | 0.69208713 |
150 | MP0003879_abnormal_hair_cell | 0.69094851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased mean platelet volume (HP:0011877) | 7.27301150 |
2 | Prolonged bleeding time (HP:0003010) | 7.16741774 |
3 | Menorrhagia (HP:0000132) | 6.97550381 |
4 | Abnormal platelet volume (HP:0011876) | 6.47795361 |
5 | Purpura (HP:0000979) | 6.38802237 |
6 | Petechiae (HP:0000967) | 6.38649186 |
7 | Myokymia (HP:0002411) | 4.38610803 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.28214281 |
9 | Epistaxis (HP:0000421) | 4.24680025 |
10 | Pheochromocytoma (HP:0002666) | 4.23760414 |
11 | Neuroendocrine neoplasm (HP:0100634) | 4.01973418 |
12 | Acanthocytosis (HP:0001927) | 4.01387010 |
13 | Cerebral hypomyelination (HP:0006808) | 3.91026017 |
14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.88452204 |
15 | Acute necrotizing encephalopathy (HP:0006965) | 3.84446094 |
16 | Gingival bleeding (HP:0000225) | 3.83363246 |
17 | Abnormality of glycolysis (HP:0004366) | 3.78545400 |
18 | Increased serum pyruvate (HP:0003542) | 3.78545400 |
19 | Acute encephalopathy (HP:0006846) | 3.73167398 |
20 | Abnormal platelet function (HP:0011869) | 3.63625392 |
21 | Impaired platelet aggregation (HP:0003540) | 3.63625392 |
22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.58172633 |
23 | Abnormal gallbladder physiology (HP:0012438) | 3.31421808 |
24 | Cholecystitis (HP:0001082) | 3.31421808 |
25 | Hypoglycemic coma (HP:0001325) | 3.28850638 |
26 | Mitochondrial inheritance (HP:0001427) | 3.17252647 |
27 | Leukodystrophy (HP:0002415) | 3.16543859 |
28 | Generalized aminoaciduria (HP:0002909) | 3.12865074 |
29 | Intrahepatic cholestasis (HP:0001406) | 3.11549354 |
30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.10527385 |
31 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.10527385 |
32 | Hepatocellular necrosis (HP:0001404) | 3.07792096 |
33 | Progressive macrocephaly (HP:0004481) | 3.02101967 |
34 | Neurofibrillary tangles (HP:0002185) | 3.01659753 |
35 | Poikilocytosis (HP:0004447) | 3.00317535 |
36 | Abnormality of the corticospinal tract (HP:0002492) | 2.97583299 |
37 | Limb dystonia (HP:0002451) | 2.90382640 |
38 | Bundle branch block (HP:0011710) | 2.89546710 |
39 | Paralysis (HP:0003470) | 2.88176633 |
40 | Cerebral edema (HP:0002181) | 2.87332987 |
41 | Increased CSF lactate (HP:0002490) | 2.84730490 |
42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.79794734 |
43 | CNS hypomyelination (HP:0003429) | 2.71508870 |
44 | Hepatic necrosis (HP:0002605) | 2.68587707 |
45 | Abnormal pupillary function (HP:0007686) | 2.61802791 |
46 | Focal motor seizures (HP:0011153) | 2.60584485 |
47 | Dyschromatopsia (HP:0007641) | 2.60099940 |
48 | Papillary thyroid carcinoma (HP:0002895) | 2.59171529 |
49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.55321561 |
50 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.49721620 |
51 | Ventricular fibrillation (HP:0001663) | 2.48451302 |
52 | Spastic gait (HP:0002064) | 2.47835475 |
53 | Sensory axonal neuropathy (HP:0003390) | 2.46800757 |
54 | Exercise-induced muscle cramps (HP:0003710) | 2.44842164 |
55 | Rimmed vacuoles (HP:0003805) | 2.42853444 |
56 | Abnormality of lateral ventricle (HP:0030047) | 2.41718323 |
57 | Ankle clonus (HP:0011448) | 2.38850034 |
58 | Hyperthyroidism (HP:0000836) | 2.36576905 |
59 | Spastic paraparesis (HP:0002313) | 2.36540015 |
60 | Scanning speech (HP:0002168) | 2.35615316 |
61 | Lactic acidosis (HP:0003128) | 2.33642991 |
62 | Cerebral inclusion bodies (HP:0100314) | 2.32837747 |
63 | Myoglobinuria (HP:0002913) | 2.31235751 |
64 | Poor suck (HP:0002033) | 2.29818171 |
65 | Xanthomatosis (HP:0000991) | 2.28531329 |
66 | Delusions (HP:0000746) | 2.28479384 |
67 | Hyperventilation (HP:0002883) | 2.27138246 |
68 | Termporal pattern (HP:0011008) | 2.24915951 |
69 | Insidious onset (HP:0003587) | 2.24915951 |
70 | Cerebral hemorrhage (HP:0001342) | 2.22342799 |
71 | Atonic seizures (HP:0010819) | 2.21311118 |
72 | Nemaline bodies (HP:0003798) | 2.20370271 |
73 | Muscle fiber inclusion bodies (HP:0100299) | 2.19652076 |
74 | Conjunctival telangiectasia (HP:0000524) | 2.17624339 |
75 | Spontaneous abortion (HP:0005268) | 2.16069184 |
76 | Lethargy (HP:0001254) | 2.15571793 |
77 | Retinal dysplasia (HP:0007973) | 2.13490712 |
78 | Supranuclear gaze palsy (HP:0000605) | 2.12759208 |
79 | Emotional lability (HP:0000712) | 2.12659726 |
80 | Polyphagia (HP:0002591) | 2.10748210 |
81 | Choreoathetosis (HP:0001266) | 2.09174690 |
82 | Dysmetria (HP:0001310) | 2.09115281 |
83 | Increased serum lactate (HP:0002151) | 2.09002221 |
84 | Muscular hypotonia of the trunk (HP:0008936) | 2.08687394 |
85 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.07633800 |
86 | Anxiety (HP:0000739) | 2.06744881 |
87 | Hypobetalipoproteinemia (HP:0003563) | 2.06529896 |
88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06519312 |
89 | Joint hemorrhage (HP:0005261) | 2.06402554 |
90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05040202 |
91 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03944804 |
92 | Nausea (HP:0002018) | 2.03845590 |
93 | Delayed myelination (HP:0012448) | 2.01368568 |
94 | Poor speech (HP:0002465) | 2.01292046 |
95 | Epileptic encephalopathy (HP:0200134) | 2.00967268 |
96 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00899959 |
97 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00899959 |
98 | Thyroid carcinoma (HP:0002890) | 2.00847645 |
99 | Split foot (HP:0001839) | 1.99576897 |
100 | Renal Fanconi syndrome (HP:0001994) | 1.99315372 |
101 | Exercise intolerance (HP:0003546) | 1.99111669 |
102 | Peripheral hypomyelination (HP:0007182) | 1.98574105 |
103 | Respiratory failure (HP:0002878) | 1.97081862 |
104 | Rhabdomyolysis (HP:0003201) | 1.96640714 |
105 | Increased muscle lipid content (HP:0009058) | 1.96361813 |
106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95853155 |
107 | Abnormality of alanine metabolism (HP:0010916) | 1.95853155 |
108 | Hyperalaninemia (HP:0003348) | 1.95853155 |
109 | Increased hepatocellular lipid droplets (HP:0006565) | 1.94669255 |
110 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.94576437 |
111 | Testicular neoplasm (HP:0010788) | 1.93561720 |
112 | CNS demyelination (HP:0007305) | 1.93002868 |
113 | Focal seizures (HP:0007359) | 1.90686487 |
114 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90479019 |
115 | Lipid accumulation in hepatocytes (HP:0006561) | 1.89652102 |
116 | Craniofacial dystonia (HP:0012179) | 1.88883209 |
117 | Hyperglycinemia (HP:0002154) | 1.88732735 |
118 | Visual hallucinations (HP:0002367) | 1.88242442 |
119 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88033415 |
120 | Ketosis (HP:0001946) | 1.87687229 |
121 | Renal tubular acidosis (HP:0001947) | 1.87546714 |
122 | Back pain (HP:0003418) | 1.87140286 |
123 | Clonus (HP:0002169) | 1.86712810 |
124 | Tongue fasciculations (HP:0001308) | 1.86439030 |
125 | Brushfield spots (HP:0001088) | 1.85223542 |
126 | Abnormal cartilage morphology (HP:0002763) | 1.85119519 |
127 | Methylmalonic aciduria (HP:0012120) | 1.84967794 |
128 | Hypothermia (HP:0002045) | 1.84346229 |
129 | Progressive inability to walk (HP:0002505) | 1.84331190 |
130 | Heart block (HP:0012722) | 1.84319711 |
131 | Abnormal auditory evoked potentials (HP:0006958) | 1.84070970 |
132 | Generalized tonic-clonic seizures (HP:0002069) | 1.83922031 |
133 | Muscle fiber splitting (HP:0003555) | 1.83346065 |
134 | Ketoacidosis (HP:0001993) | 1.82287707 |
135 | Renal cortical cysts (HP:0000803) | 1.81872143 |
136 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81461164 |
137 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81436340 |
138 | Focal dystonia (HP:0004373) | 1.81092983 |
139 | Methylmalonic acidemia (HP:0002912) | 1.80763171 |
140 | Abnormal gallbladder morphology (HP:0012437) | 1.80755341 |
141 | Progressive external ophthalmoplegia (HP:0000590) | 1.79476756 |
142 | Hyperammonemia (HP:0001987) | 1.79328724 |
143 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78907809 |
144 | Irritability (HP:0000737) | 1.78399850 |
145 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77927687 |
146 | Athetosis (HP:0002305) | 1.77850412 |
147 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77294263 |
148 | Confusion (HP:0001289) | 1.76446446 |
149 | Torticollis (HP:0000473) | 1.76180682 |
150 | Gait imbalance (HP:0002141) | 1.75517246 |
151 | Optic disc pallor (HP:0000543) | 1.74134758 |
152 | Hypsarrhythmia (HP:0002521) | 1.73732765 |
153 | Delayed CNS myelination (HP:0002188) | 1.73576958 |
154 | Abnormality of glycine metabolism (HP:0010895) | 1.72852736 |
155 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72852736 |
156 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71960893 |
157 | Type II lissencephaly (HP:0007260) | 1.70898601 |
158 | Vaginal atresia (HP:0000148) | 1.70613444 |
159 | Exercise-induced myalgia (HP:0003738) | 1.70461749 |
160 | Arthropathy (HP:0003040) | 1.69760964 |
161 | Hepatosplenomegaly (HP:0001433) | 1.68966082 |
162 | Sudden death (HP:0001699) | 1.68961914 |
163 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.68733941 |
164 | Subaortic stenosis (HP:0001682) | 1.66728459 |
165 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.66728459 |
166 | Abnormal atrioventricular conduction (HP:0005150) | 1.63773439 |
167 | Renal tubular dysfunction (HP:0000124) | 1.60868156 |
168 | Upper limb muscle weakness (HP:0003484) | 1.59854532 |
169 | Hypoglycemic seizures (HP:0002173) | 1.59425714 |
170 | Abnormality of urine glucose concentration (HP:0011016) | 1.57959117 |
171 | Glycosuria (HP:0003076) | 1.57959117 |
172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.57837764 |
173 | Fasciculations (HP:0002380) | 1.56949279 |
174 | Bruising susceptibility (HP:0000978) | 1.56527152 |
175 | Conjugated hyperbilirubinemia (HP:0002908) | 1.56127733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 2.98791632 |
2 | BMX | 2.83999700 |
3 | LIMK1 | 2.71589053 |
4 | BCKDK | 2.55632262 |
5 | MAPKAPK5 | 2.54849113 |
6 | ARAF | 2.45740662 |
7 | OXSR1 | 2.44680798 |
8 | MAP3K9 | 2.31516969 |
9 | ILK | 2.24219191 |
10 | TNIK | 2.04980491 |
11 | NTRK3 | 2.03276429 |
12 | PIM2 | 1.98396141 |
13 | BCR | 1.94543575 |
14 | DYRK2 | 1.94322725 |
15 | CSNK1G3 | 1.93001892 |
16 | NTRK1 | 1.89534706 |
17 | EPHA4 | 1.88883370 |
18 | MARK1 | 1.88318131 |
19 | MINK1 | 1.87321755 |
20 | CDK19 | 1.82173328 |
21 | RIPK4 | 1.81699650 |
22 | MAP3K4 | 1.80505156 |
23 | MAP2K7 | 1.78414052 |
24 | DYRK3 | 1.77305951 |
25 | TRIM28 | 1.72056589 |
26 | CSNK1G2 | 1.67700833 |
27 | UHMK1 | 1.62024907 |
28 | TESK2 | 1.53252311 |
29 | ERBB3 | 1.52116011 |
30 | GRK5 | 1.51987003 |
31 | WNK4 | 1.44860144 |
32 | MAP3K12 | 1.43863562 |
33 | KSR2 | 1.43844851 |
34 | MAP2K4 | 1.41856307 |
35 | LATS2 | 1.41593488 |
36 | PAK6 | 1.39919560 |
37 | PIK3CG | 1.34364251 |
38 | PRKD3 | 1.33363704 |
39 | MAPK13 | 1.32626348 |
40 | CASK | 1.31496261 |
41 | MUSK | 1.30335205 |
42 | CSNK1A1L | 1.29186353 |
43 | PLK2 | 1.27888935 |
44 | CSNK1G1 | 1.24083685 |
45 | CAMK2G | 1.22682295 |
46 | BMPR2 | 1.22455690 |
47 | CAMK2B | 1.20520990 |
48 | BRAF | 1.20472569 |
49 | ERBB4 | 1.17444220 |
50 | EPHB1 | 1.14188111 |
51 | TESK1 | 1.13076357 |
52 | BUB1 | 1.11221648 |
53 | CDK5 | 1.11112113 |
54 | PKN1 | 1.07770142 |
55 | * CDK14 | 1.07177342 |
56 | DYRK1B | 1.06888782 |
57 | NEK6 | 1.06623965 |
58 | EPHB2 | 1.05556068 |
59 | SGK223 | 1.04542189 |
60 | SGK494 | 1.04542189 |
61 | PHKG2 | 1.04435864 |
62 | PHKG1 | 1.04435864 |
63 | CAMK2D | 1.02878914 |
64 | NME1 | 1.02875783 |
65 | TEC | 1.02609163 |
66 | AKT3 | 1.02528047 |
67 | CAMK2A | 1.00488956 |
68 | PAK1 | 0.98239802 |
69 | ROCK2 | 0.94980868 |
70 | FER | 0.89495894 |
71 | PAK3 | 0.87631218 |
72 | IRAK2 | 0.87085481 |
73 | PRKD1 | 0.86785722 |
74 | NTRK2 | 0.83902468 |
75 | TYRO3 | 0.83812565 |
76 | * CDK18 | 0.82771460 |
77 | STK24 | 0.82690745 |
78 | CDK8 | 0.81090066 |
79 | EIF2AK1 | 0.78837713 |
80 | * CDK15 | 0.78794377 |
81 | OBSCN | 0.77238338 |
82 | DYRK1A | 0.77162181 |
83 | MAP3K6 | 0.77027853 |
84 | TAOK1 | 0.71847454 |
85 | PRKCG | 0.71419698 |
86 | TAOK3 | 0.71302327 |
87 | * CDK11A | 0.70912065 |
88 | PRKACG | 0.70239357 |
89 | CAMKK2 | 0.69869920 |
90 | STK3 | 0.69443428 |
91 | MAP3K5 | 0.69169165 |
92 | PRPF4B | 0.68060784 |
93 | MET | 0.67580227 |
94 | MATK | 0.67487554 |
95 | FGR | 0.67282183 |
96 | PINK1 | 0.66583072 |
97 | WNK1 | 0.65932585 |
98 | BMPR1B | 0.65516693 |
99 | STK16 | 0.65207775 |
100 | PDK2 | 0.65095070 |
101 | ERBB2 | 0.63343149 |
102 | VRK1 | 0.62998687 |
103 | PNCK | 0.62557126 |
104 | TNK2 | 0.61272102 |
105 | DAPK3 | 0.60581765 |
106 | RAF1 | 0.60508739 |
107 | MAP3K2 | 0.59641892 |
108 | MAP3K11 | 0.58977308 |
109 | DAPK2 | 0.57747894 |
110 | AKT2 | 0.57178334 |
111 | ABL2 | 0.56320626 |
112 | DMPK | 0.55318316 |
113 | MYLK | 0.54263416 |
114 | AURKA | 0.53674923 |
115 | STK38L | 0.53354483 |
116 | BRSK2 | 0.52622476 |
117 | PRKG1 | 0.51740465 |
118 | NEK1 | 0.51309189 |
119 | MARK2 | 0.49651617 |
120 | PKN2 | 0.49647212 |
121 | RET | 0.48885454 |
122 | DAPK1 | 0.48667720 |
123 | PDPK1 | 0.48575843 |
124 | SCYL2 | 0.48415202 |
125 | MAPK12 | 0.47860253 |
126 | MST4 | 0.47130929 |
127 | NEK9 | 0.46741093 |
128 | ACVR1B | 0.45440158 |
129 | LMTK2 | 0.44708415 |
130 | CSF1R | 0.44441814 |
131 | INSRR | 0.44195389 |
132 | ADRBK2 | 0.43872125 |
133 | BTK | 0.43049864 |
134 | CAMK1 | 0.42890202 |
135 | MAPKAPK3 | 0.42513596 |
136 | CSNK1E | 0.42063988 |
137 | ADRBK1 | 0.42058594 |
138 | MAP2K1 | 0.41723304 |
139 | PRKACA | 0.41436409 |
140 | PTK2B | 0.40430288 |
141 | PRKACB | 0.40151097 |
142 | PRKCE | 0.40087195 |
143 | GRK1 | 0.37265986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.30137161 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 2.92217081 |
3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.66781165 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41637483 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.38537026 |
6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.36375053 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.30408959 |
8 | Platelet activation_Homo sapiens_hsa04611 | 2.29535518 |
9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.12955836 |
10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.12241614 |
11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.08988197 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02246408 |
13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.00274088 |
14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.99147978 |
15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.96632797 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93252560 |
17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92006103 |
18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.86765724 |
19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.77538676 |
20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74431565 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73980699 |
22 | Protein export_Homo sapiens_hsa03060 | 1.73398552 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67341049 |
24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.65780233 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65651546 |
26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64756432 |
27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60242051 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59931462 |
29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49583798 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46470482 |
31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42202064 |
32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40608195 |
33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36702931 |
34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32760311 |
35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.29679175 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.24318063 |
37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.21482966 |
38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20826392 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20600325 |
40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17428346 |
41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16673536 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16107308 |
43 | Proteasome_Homo sapiens_hsa03050 | 1.14163845 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13284386 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12184729 |
46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11436636 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09980136 |
48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.07131496 |
49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06845260 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06737150 |
51 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05743302 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03893606 |
53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03511492 |
54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02429916 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00170435 |
56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98031939 |
57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.97815530 |
58 | RNA polymerase_Homo sapiens_hsa03020 | 0.97790168 |
59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97713146 |
60 | Insulin secretion_Homo sapiens_hsa04911 | 0.93170968 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92133749 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91310694 |
63 | Bile secretion_Homo sapiens_hsa04976 | 0.90396272 |
64 | Alcoholism_Homo sapiens_hsa05034 | 0.89880037 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88589704 |
66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88310826 |
67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86966980 |
68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86645620 |
69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83665115 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80460021 |
71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80423949 |
72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79584783 |
73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78207851 |
74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78061627 |
75 | Taste transduction_Homo sapiens_hsa04742 | 0.77922496 |
76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77057915 |
77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.76475497 |
78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75657023 |
79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74514099 |
80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73709473 |
81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70599071 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69755581 |
83 | Morphine addiction_Homo sapiens_hsa05032 | 0.68416752 |
84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66841060 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65689070 |
86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65456860 |
87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64469036 |
88 | Mismatch repair_Homo sapiens_hsa03430 | 0.62025373 |
89 | * Endocytosis_Homo sapiens_hsa04144 | 0.59302380 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58020849 |
91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57844221 |
92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57333526 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55786684 |
94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55617824 |
95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55599271 |
96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55403485 |
97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53365453 |
98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53087213 |
99 | Ribosome_Homo sapiens_hsa03010 | 0.52561937 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52347791 |
101 | Salivary secretion_Homo sapiens_hsa04970 | 0.52091092 |
102 | Long-term depression_Homo sapiens_hsa04730 | 0.51927226 |
103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50769835 |
104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49724664 |
105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49336162 |
106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49173998 |
107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48854911 |
108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48630819 |
109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47340022 |
110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46236550 |
111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44961165 |
112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44566827 |
113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43503454 |
114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42009501 |
115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41026187 |
116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40671004 |
117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39155942 |
118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34825162 |
119 | Gap junction_Homo sapiens_hsa04540 | 0.33581616 |
120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33138315 |
121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32014002 |
122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31732925 |
123 | Purine metabolism_Homo sapiens_hsa00230 | 0.30965670 |
124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30929866 |
125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30191354 |
126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29814657 |
127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29468819 |